INTERNATIONAL PATENT: AURIGENE ONCOLOGY LIMITED FILES APPLICATION FOR "PHARMACEUTICALLY ACCEPTABLE SALT OF A CD47-SIRP ALPHA PATHWAY INHIBITOR"

GENEVA, April 28 -- AURIGENE ONCOLOGY LIMITED (39/40 (P), KIADB Industrial Area, Electronics City Phase II, KarnatakaBangalore 560100) filed a patent application (PCT/IB2024/060259) for "PHARMACEUTICALLY ACCEPTABLE SALT OF A CD47-SIRP ALPHA PATHWAY INHIBITOR" on Oct 18, 2024. With publication no. WO/2025/083628, the details related to the patent application was published on Apr 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SEETHARAMAIAH SETTY, Sudarshan Naremaddepalli (# 142, Pyramid Mahika, Jakkur Main Road Shivanahlli, VTC: Jakkur, PO: YelhankaBangalore 560064), SASIKUMAR, Pottayil G...